These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 22042809)

  • 21. Approach to Antihypertensive Therapy.
    Reddy P; Dupree L
    Am J Ther; 2016; 23(2):e451-73. PubMed ID: 25719531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W; Tepel M; van der Giet M
    MMW Fortschr Med; 2004 May; 146(22):31-4. PubMed ID: 15373106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension.
    Hermida RC; Ayala DE; Fernández JR; Calvo C
    Hypertension; 2008 Jan; 51(1):69-76. PubMed ID: 17968001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should two-drug initial therapy for hypertension be recommended for all patients?
    Cowart JB; Taylor AA
    Curr Hypertens Rep; 2012 Aug; 14(4):324-32. PubMed ID: 22661332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
    Stafford RS; Monti V; Furberg CD; Ma J
    Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment of hypertension in inpatients. Role of fixed dose combinations].
    Scholz C; Höer A; Behnsen S; Haussler B
    MMW Fortschr Med; 2011 Mar; 153 Suppl 1():26-32. PubMed ID: 21591328
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF; Gerocarni B; Rosticci M; Borghi C
    Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
    Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
    Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
    Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
    BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Persistence and adherence: Comparison between the five classes diuretics, beta-blocker, calcium channel blockers, ACE-inhibitors and angiotensin receptor blockers as the first line in antihypertensive therapy].
    Rossol-Haseroth K; Eckes L; Schroeder A
    MMW Fortschr Med; 2011 Mar; 153 Suppl 1():21-5. PubMed ID: 21591327
    [No Abstract]   [Full Text] [Related]  

  • 39. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
    Lazich I; Bakris GL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin receptor blockers for management of hypertension.
    Catanzaro DF; Frishman WH
    South Med J; 2010 Jul; 103(7):669-73. PubMed ID: 20531060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.